Viewing Study NCT06847334


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-01-07 @ 5:45 PM
Study NCT ID: NCT06847334
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-26
First Post: 2025-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module